Tether Bets $200 Million on Blackrock Neurotech

Tether has funneled $200 million into BlackRock Neurotech, securing its position as the majority stakeholder.

This strategic investment by Tether marks a pivotal shift toward Brain-Computer-Interface (BCI) technology, emphasizing the company’s vision to improve human capabilities through technology.

Tether Expands Portfolio with BlackRock Neurotech Investment

BlackRock Neurotech has been at the forefront of BCI development. Operating out of Salt Lake City, Utah, the company has developed cutting-edge technologies that assist individuals with severe neurological conditions. The devices enable users to perform complex actions such as controlling robotic arms, navigating wheelchairs, and even driving cars using only their thoughts.

The investment from Tether will primarily support the commercialization and broader rollout of BlackRock’s medical solutions. Additionally, it will bolster ongoing research and development efforts to maintain BlackRock Neurotech’s leadership in the BCI space.

Paolo Ardoino, CEO of Tether, remarked on the investment as a step forward. It aims to integrate more deeply with transformative technologies that bridge human cognitive capabilities and advanced computing.

“Blackrock Neurotech is just the beginning of our journey through Tether Evo to venture into projects that redefine the boundaries of what’s possible at the intersection of technological innovation and human potential,” Ardoino said.

Echoing this sentiment, Florian Solzbacher, Co-Founder of Blackrock Neurotech, highlighted the partnership’s potential to advance healthcare and technological integration significantly.

Read more: 9 Best Crypto Wallets to Store Tether (USDT)

This strategic partnership reflects Tether’s diversification from its stablecoin roots and aligns with its broader vision to harness the power of technology in different sectors.